CD34 and acute myeloid leukemia: Transcriptome analysis of Low-ROS CD34+ cells in AML patients demonstrated gene expression patterns associated with increased stemness and reduced differentiation and apoptosis pathways compared to high-ROS CD34+ cells[107].